Top news of the week: 24.03.2020.
#COVID19 #coronavirus #Biotech #patients #LifeSciences
Startups
London-based venture capital firm @SynconaLtd warns of "serious delays" to clinical trials across its portfolio of at least 3 months. They also said they don't anticipate that the delays will impact reported valuations of their privately held companies. https://t.co/TxNQvhFUL2
OpenVC shop Syncona warns of company trial delays as COVID-19 pandemic deepens
Life science venture capital firm Syncona is warning of serious delays to studies across its biotech portfolio.
RT @AndyBiotech: Two bits of good news on therapeutics for #COVID19
Among 1st wave #coronavirus antivirals, China claims good efficacy for Favipiravir
https://t.co/7gw6Vv2vkD
In 2nd wave antibody approach, Regeneron move fwd its time frame to enter human by early summer
https://t.co/5XgHOaWd5y https://t.co/8tPDW8X5Mn
OpenRegeneron Announces Important Advances in Novel COVID-19 Antibody Program
/PRNewswire/ -- Regeneron has identified hundreds of virus-neutralizing antibodies; plans to initiate large-scale manufacturing by mid-April with antibody...
RT @nkjellson: My Covidcrush: @juliesunderland // Love in the Time of Coronavirus - https://t.co/SQbjHKClmR https://t.co/f5g4hHeTa1
OpenYour Edge in Biotech.
Timmerman Report is an independently-owned subscription publication that provides timely, in-depth biotech news and analysis.
How San Diego #Biotech Leaders Are Adapting to #Coronavirus Concerns https://t.co/gsNitR0PNo @CABiotech @TakedaPharma https://t.co/VktXJar3oD
OpenHow San Diego Biotech Leaders Are Adapting to Coronavirus Concerns
Three hundred Takeda employees from the Japanese pharma giant’s California research center have been working from home for 10 days straight. Neurocrine
MA is the best place in the world for the #LifeSciences & now its leading cluster is coming together to help fight #COVID19 & rapidly develop vaccines, diagnostic tests, & treatments for #patients everywhere https://t.co/eoA4fYo5nM @BostonGlobe
OpenMassachusetts life-sciences industry at forefront of worldwide fight against coronavirus
Companies in Massachusetts are scrambling to develop potential vaccines, drugs, and tests while researchers at Harvard, MIT, and other schools are studying everything from genetic ...
Great piece by @jmaxlevin in @timmermanreport on how the biopharmaceutical industry “immediately stepped forward” to combat #COVID19. https://t.co/ml4Mvs0N7H
OpenThe Biopharmaceutical Counterattack
The latest contagious and deadly global virus, COVID-19, is invisibly sprinting across the world and across America. As the crisis engulfs our nation, it has exposed failures to heed the ...
RT @nkjellson: My Covidcrush: @juliesunderland // Love in the Time of Coronavirus - https://t.co/SQbjHKClmR https://t.co/f5g4hHeTa1
OpenLove in the Time of Coronavirus
The Seattle community is about two weeks ahead of the rest of the US in adapting to our new coronavirus-driven reality. My three kids have been out of school for two weeks now. Although ...
RT @BentheFidler: Here's @realJacobBell with a look at how some Seattle biotechs are handling the #coronavirus outbreak.
In hard-hit Seattle, coronavirus pushes biotechs to a new normal https://t.co/ngDXRTDxcR #covid19
OpenIn hard-hit Seattle, coronavirus pushes biotechs to a new normal
Local drugmakers are on the frontlines of a pandemic that's affecting travel, clinical research and daily operations. It's forcing them to adapt quickly.